Zoledronic Acid
Concept
Vocabulary Service
Overview
subject area of
-
A community-based clinical trial of Intra-Venous zOledRonic acid once Yearly in comparison to oral bisphosphonates in postmenopausal women with osteoporosis: The IVORY trial Academic Article
-
A phase I dose-ranging trial of monthly infusions of zoledronic acid for the treatment of osteolytic bone metastases. Academic Article
-
Antifracture Efficacy and Reduction of Mortality in Relation to Timing of the First Dose of Zoledronic Acid After Hip Fracture Academic Article
-
Association between timing of zoledronic acid infusion and hip fracture healing Academic Article
-
Bisphosphonate-Induced Orbital Inflammation: A Case Series and Review Academic Article
-
Bone Health and Bone-targeted Therapies for Prostate Cancer: a Programme in Evidence-based Care — Cancer Care Ontario Clinical Practice Guideline Academic Article
-
Bone Turnover Markers as Predictors of Skeletal Complications in Prostate Cancer, Lung Cancer, and Other Solid Tumors Academic Article
-
Changes in cross-sectional geometry of the distal femoral metaphysis associated with inflammatory arthritis are reduced by a bisphosphonate (zoledronate) Academic Article
-
Clinical Risk Factors for Recurrent Fracture after Hip Fracture: A Prospective Study Academic Article
-
Clinical Utility of Biochemical Markers of Bone Metabolism for Improving the Management of Patients with Advanced Multiple Myeloma Academic Article
-
Does the number of 6-monthly adjuvant zoledronate infusions received affect treatment efficacy for early breast cancer? A sub-study of ABCSG-12 Academic Article
-
Effect of bisphosphonates on pain and quality of life in patients with bone metastases Academic Article
-
Effect of zoledronic acid on the doxycycline-induced decrease in tumour burden in a bone metastasis model of human breast cancer Academic Article
-
Efficacy and safety of a once-yearly i.v. Infusion of zoledronic acid 5 mg versus a once-weekly 70-mg oral alendronate in the treatment of male osteoporosis: A randomized, multicenter, double-blind, active-controlled study Academic Article
-
Efficacy of Bisphosphonates in the Management of Skeletal Complications of Bone Metastases and Selection of Clinical Endpoints Academic Article
-
Efficacy of bisphosphonates in the management of skeletal complications of bone metastases and selection of clinical endpoints. Academic Article
-
Markers of Bone Metabolism and Survival in Men with Hormone-Refractory Metastatic Prostate Cancer Academic Article
-
Normalization of bone markers is associated with improved survival in patients with bone metastases from solid tumors and elevated bone resorption receiving zoledronic acid Academic Article
-
Once-Yearly Zoledronic Acid in Older Men Compared with Women with Recent Hip Fracture Academic Article
-
Optimal management of metastatic bone disease Academic Article
-
Optimal management of metastatic bone disease Academic Article
-
Oral bisphosphonates Academic Article
-
Patient Management, and Time and Health Care Resource Utilization Associated with the Use of Intravenous Bisphosphonates For Patients with Metastatic Bone Disease: A Delphi Study Academic Article
-
Patient and Physician Decisional Factors Regarding Hypercalcemia of Malignancy Treatment: A Novel Mixed-Methods Study Academic Article
-
Phase II Trial Evaluating the Palliative Benefit of Second-Line Zoledronic Acid in Breast Cancer Patients With Either a Skeletal-Related Event or Progressive Bone Metastases Despite First-Line Bisphosphonate Therapy Academic Article
-
Predictive Value of Bone Resorption and Formation Markers in Cancer Patients With Bone Metastases Receiving the Bisphosphonate Zoledronic Acid Conference Paper
-
Predictors of Skeletal Complications in Men with Hormone-Refractory Metastatic Prostate Cancer Academic Article
-
Role of Bone-Modifying Agents in Metastatic Breast Cancer: An American Society of Clinical Oncology–Cancer Care Ontario Focused Guideline Update Academic Article
-
Subgroup Variations in Bone Mineral Density Response to Zoledronic Acid After Hip Fracture Academic Article
-
Symptomatic skeletal-related events in patients receiving longer term bone-modifying agents for bone metastases from breast and castration resistant prostate cancers Academic Article
-
The HORIZON Recurrent Fracture Trial: design of a clinical trial in the prevention of subsequent fractures after low trauma hip fracture repair Academic Article
-
The Pharmacokinetics and Pharmacodynamics of Zoledronic Acid in Cancer Patients with Varying Degrees of Renal Function Conference Paper
-
The Use of Zoledronic Acid, a Novel, Highly Potent Bisphosphonate, for the Treatment of Hypercalcemia of Malignancy Academic Article
-
Time and Labor Costs Associated With Administration of Intravenous Bisphosphonates for Breast or Prostate Cancer Patients With Metastatic Bone Disease: A Time and Motion Study Academic Article
-
Tolerability of Different Dosing Regimens of Bisphosphonates for the Treatment of Osteoporosis and Malignant Bone Disease Academic Article
-
Use of Adjuvant Bisphosphonates and Other Bone-Modifying Agents in Breast Cancer: A Cancer Care Ontario and American Society of Clinical Oncology Clinical Practice Guideline Academic Article
-
Which Bone-Modifying Agent is Associated with Better Outcomes in Patients with Skeletal Metastases from Lung Cancer? A Systematic Review and Network Meta-analysis Academic Article
-
Zoledronate (CGP 42'446), a bisphosphonate, protects against metaphyseal intracortical defects in experimental inflammatory arthritis Academic Article
-
Zoledronic Acid Is Superior to Pamidronate in the Treatment of Hypercalcemia of Malignancy: A Pooled Analysis of Two Randomized, Controlled Clinical Trials Academic Article
-
Zoledronic Acid and Survival in Breast Cancer Patients with Bone Metastases and Elevated Markers of Osteoclast Activity Academic Article
-
Zoledronic Acid and Survival in Patients with Metastatic Bone Disease from Lung Cancer and Elevated Markers of Osteoclast Activity Academic Article
-
Zoledronic acid and survival in breast cancer patients with bone metastases and elevated markers of osteoclast activity. Academic Article
-
Zoledronic acid in the treatment of hypercalcemia of malignancy: Results of the international clinical development program Academic Article
-
Zoledronic acid is superior to pamidronate for the treatment of bone metastases in breast carcinoma patients with at least one osteolytic lesion Academic Article
-
Zoledronic acid results in better health-related quality of life following hip fracture: the HORIZON–Recurrent Fracture Trial Academic Article
-
Zoledronic acid use in cancer patients Academic Article